Mullerian Inhibiting Substance
Taylor, Lesli A.
Massachusetts General Hospital, Boston, MA, United States
See 4 grants from Lesli Taylor
See grants from Massachusetts General Hospital
Recent in Grantomics:
University of Virginia
vs. funders. Who wins?
How should you pick the next fundable research topic?
Recently viewed grants:
Risk Factors for Microscopic Colitis
Modeling Familial Dilated Cardiomyopathy Using Patient-derived Induced Pluripotent Stem Cells
NMDA receptor modulation for hyperarousal in PTSD
Irreversible Electroporation Ablation for Colorectal Metastases to the Lung
The Development of an Ultra-Short-Wavelength RF Undulator
Recently added grants:
Multifactor mRNA Mediated T Cell Reprogramming for Systemic Lupus Erythematosus
Molecular mechanism of general stress signaling in Brucella abortus
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection
Supramolecular nanofiber vaccines
A Systems Biology Approach for Targeted Drug Discovery for Leishmaniasis
National Institute of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Postdoctoral Individual National Research Service Award (F32)
Clinical Sciences Subcommittee 1 (CLN)
Massachusetts General Hospital
MacLaughlin, D T; Levin, R K; Catlin, E A et al.
Identification of mullerian inhibiting substance specific binding in human cell lines.
Horm Metab Res 24:570-5
Be the first to comment on Lesli Taylor's grant
Share this grant: